HIV Vaccine: Why There Isn’t One Yet, and What Comes Next
There's still no HIV vaccine. See why Mosaico and other big trials failed, what 2025 mRNA germline-targeting studies found and how the PrEP shot differs.
There's still no HIV vaccine. See why Mosaico and other big trials failed, what 2025 mRNA germline-targeting studies found and how the PrEP shot differs.
THE experimental M72/AS01 tuberculosis (TB) vaccine has shown a favourable safety profile in people living with HIV who are on antiretroviral therapy (ART), boosting prospects for...
NASHVILLE, Tenn. — Two doses of hepatitis B virus vaccine with CpG adjuvant may not be sufficient for people with HIV who do not respond to an initial vaccination series, according...
An injectable HIV drug could save huge numbers of people from getting infected in Uganda.
But shortages of lenacapavir mean that those who need it the most often can't get treate...
The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensivel...
"May be a surprisingly effective route to HIV cure."ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.
The first supplies are expected to reach people by the end of 2026, with broader rollout across eligible countries expected in 2027
A lower-cost version of the twice-yearly HIV prevention injection lenacapavir has received tentative approval from […] The post US FDA Grants Tentative Approval for $40-a-Year HIV...
A new study finds that the VRC01 antibody initially protects against HIV infection, but resistant strains can cause breakthrough infections as antibody levels decline, highlighting...
Learn how a single dose of an antibody targeting immune cells helped some monkeys stay free of detectable virus long after stopping treatment.
The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV - a big step toward making the drug available inexpensivel...
About 4,700 people have already started using the injection across 12 sites since February, with officials recording around 500 new initiations each week. The post Zimbabwe Gears U...
FRIDAY, Oct. 9, 2026 — A new long-acting drug combo can restore control over HIV for patients whose virus has developed resistance to commonly used medications, researchers report...
Utafiti mpya wa kisayansi umeibua matumaini katika mapambano dhidi ya Virusi Vya Ukimwi (VVU), baada ya kubaini kuwa kingamwili maalumu zinaweza kuchelewesha kwa kiasi kikubwa kure...
In the red light district in Mbarara, a city in western Uganda known in part for sex tourism, a sex worker named Lisa Mutoni insists on using condoms when men enter her room, to pr...
As vaccine against Bundibugyo Ebola virus is still under development, calls grow for use of ERVEBO to protect more people at risk today
[Daily Trust] The US Food and Drug Administration on Monday approved a low-cost version of a twice-yearly HIV prevention shot, bringing the breakthrough drug closer to market in lo...
[allAfrica] More than a century after the BCG vaccine was licensed, new tuberculosis vaccines could arrive in 2029. Gavi says the groundwork has to start now.
[RFI] Five months into the Ebola outbreak in the Democratic Republic of Congo, there is still no approved vaccine against the rare Bundibugyo strain that has now caused more than 4...
Phase One trial involves an experimental vaccine candidate known as ChAdOx1 BDBV. It's being conducted by Ugandan researchers alongside colleagues from London and University of Oxf...
A pivotal trial of vaccines against the strain of Ebola that is driving a deadly outbreak across parts of Africa has begun in the Democratic Republic of Congo, where the epidemic o...
ACI-7104, AC Immune’s experimental vaccine for early Parkinson’s disease, was generally safe and triggered an immune response against aggregated alpha-synuclein, according to resul...
The trial, named Tumaini, which means “hope” in Swahili, will assess vaccine candidates designed to protect against the Bundibugyo virus, for which no vaccine has been approved The...
Ugandan participants in a clinical safety study received an Oxford-developed Ebola vaccine last week.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.